Physician

Mark F. Young, M.D.

According to 2025 Medicare claims, Mark Young, M.D. (NPI: 1568466969) practices gastroenterology in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is GASTROINTESTINAL ASSOCIATES OF NORTHEAST TENNESSEE, PC (NPI: 1578529632; TIN: 621508557) and primary practice location at 37604-6008.

Young's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 519 traditional Medicare patients, billed 8,174 HCPCS/CPT codes, and received $221,764 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,147 prescription claims across 633 beneficiaries totaling $113,267 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 67 records totaling $1,107. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $126,393 to $221,764. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $547,327 to $113,267. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	625	1,433	$126,393
2016	598	1,340	$115,835
2017	581	1,200	$100,028
2018	556	1,119	$98,864
2019	653	1,365	$117,145
2020	539	1,288	$110,136
2021	606	1,332	$128,327
2022	540	1,710	$121,190
2023	585	5,616	$176,993
2024	519	8,174	$221,764

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	481	1,331	$547,327
2016	574	1,414	$806,095
2017	579	1,383	$518,714
2018	638	1,544	$562,711
2019	605	1,450	$373,254
2020	499	1,245	$506,714
2021	653	1,275	$225,288
2022	681	1,203	$148,542
2023	656	1,211	$165,433
2024	633	1,147	$113,267

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	97	97	$202
45380	Biopsy of large bowel using a flexible endoscope	110	111	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	102	132	$92
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	91	92	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	85	101	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	77	3,090	$54,335
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	119	154	$7,044
Sutab	Sod Sulf/Pot Chloride/Mag Sulf	24	37	$3,743
Pantoprazole Sodium	Pantoprazole Sodium	299	24,267	$3,130
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	128	133	$2,081

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	67	$1,107	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark F. Young, M.D.?

Tedicare shows public-source Medicare data for Mark F. Young, M.D. (NPI 1568466969), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark F. Young, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark F. Young, M.D.?

Mark F. Young, M.D. is linked to GASTROINTESTINAL ASSOCIATES OF NORTHEAST TENNESSEE, PC (billing NPI 1578529632) in the available physician profile data.

Does Mark F. Young, M.D. have Open Payments data?

Mark F. Young, M.D. has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.